Investigating how amyloid-beta proteins spread in Alzheimer's disease

Role of circulating Abeta seeds and peripheral tissue damage in Alzheimer's disease pathogenesis

NIH-funded research University of Texas Hlth Sci Ctr Houston · NIH-10875740

This study is looking at how certain proteins related to Alzheimer's disease move through the blood and affect the body, with the goal of finding new ways to diagnose and treat the disease for people living with it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10875740 on NIH RePORTER

What this research studies

This research explores the role of amyloid-beta (Aβ) proteins in the development of Alzheimer's disease by examining how these proteins spread through the blood and affect peripheral tissues. The study aims to identify and characterize biologically active Aβ aggregates found in the blood of Alzheimer's patients, which may contribute to the progression of the disease. By understanding the mechanisms of Aβ spread and clearance, the research seeks to develop new diagnostic and therapeutic strategies targeting these aggregates. The approach includes using animal models and advanced laboratory techniques to analyze the presence and impact of Aβ in the bloodstream.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease who exhibit symptoms related to amyloid-beta accumulation.

Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to amyloid-beta pathology may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new diagnostic tools and treatment options for Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding the role of amyloid-beta in Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.